[go: up one dir, main page]

AU5762896A - 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and the ir use as drugs - Google Patents

3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and the ir use as drugs

Info

Publication number
AU5762896A
AU5762896A AU57628/96A AU5762896A AU5762896A AU 5762896 A AU5762896 A AU 5762896A AU 57628/96 A AU57628/96 A AU 57628/96A AU 5762896 A AU5762896 A AU 5762896A AU 5762896 A AU5762896 A AU 5762896A
Authority
AU
Australia
Prior art keywords
alkoxypyridine
drugs
preparation
carboxylic acid
acid amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57628/96A
Inventor
Karl-Heinz Baringhaus
Martin Bickel
Georg Tschank
Klaus Weidmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU5762896A publication Critical patent/AU5762896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AU57628/96A 1996-04-30 1996-04-30 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and the ir use as drugs Abandoned AU5762896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/001793 WO1997041103A1 (en) 1996-04-30 1996-04-30 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs

Publications (1)

Publication Number Publication Date
AU5762896A true AU5762896A (en) 1997-11-19

Family

ID=8166212

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57628/96A Abandoned AU5762896A (en) 1996-04-30 1996-04-30 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and the ir use as drugs

Country Status (7)

Country Link
EP (1) EP0900202A1 (en)
JP (1) JP2000509047A (en)
KR (1) KR20000065090A (en)
AU (1) AU5762896A (en)
CA (1) CA2253282A1 (en)
NO (1) NO984878L (en)
WO (1) WO1997041103A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803592A1 (en) * 2000-01-06 2001-07-13 Aventis Cropscience Sa NOVEL DERIVATIVES OF 3-HYDROXYPICOLINIC ACID, PROCESS FOR THEIR PREPARATION AND FUNGICIDAL COMPOSITIONS CONTAINING SAME
EP1379630B1 (en) 2001-03-21 2012-09-26 Isis Innovation Limited Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
EP1463823B1 (en) * 2001-12-06 2013-03-06 Fibrogen, Inc. Methods of increasing endogenous erythropoietin (epo)
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
LT3357911T (en) 2006-06-26 2022-08-10 Akebia Therapeutics Inc. Prolyl hydroxylase inhibitors and methods of use
RS52870B (en) 2009-11-06 2013-12-31 Aerpio Therapeutics Inc. INHIBITOR PROLIL HYDROXYLASE
NO2686520T3 (en) 2011-06-06 2018-03-17
JP2014522410A (en) 2011-06-06 2014-09-04 アケビア セラピューティクス インコーポレイテッド Compounds and compositions for stabilizing hypoxia-inducible factor-2α as a method for cancer treatment
EP2938191B1 (en) 2012-12-28 2018-01-31 Dow AgroSciences LLC Synergistic fungicidal mixtures for fungal control in cereals
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia
RU2021125455A (en) 2013-11-15 2021-10-05 Экебиа Терапьютикс, Инк. SOLID FORMS {[5- (3-CHLOROPHENYL) -3-HYDROXYPIRIDINE-2-CARBONYL] AMINO} ACETIC ACID, THEIR COMPOSITIONS AND APPLICATIONS
CA2972034A1 (en) * 2014-12-30 2016-07-07 Dow Agrosciences Llc Picolinamides with fungicidal activity
RU2708392C2 (en) 2014-12-30 2019-12-06 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Picolinamide compounds with fungicidal activity
JP2018500362A (en) 2014-12-30 2018-01-11 ダウ アグロサイエンシィズ エルエルシー Use of picolinamide compounds having fungicidal activity
EP3240419B1 (en) * 2014-12-30 2020-05-06 Dow Agrosciences LLC Picolinamide compounds with fungicidal activity
MX2017008442A (en) 2014-12-30 2017-10-02 Dow Agrosciences Llc Use of picolinamides as fungicides.
BR112017015852A2 (en) 2015-01-23 2018-03-27 Akebia Therapeutics Inc crystal form, hemichalic salt, hemicalic salt dihydrate, hydrous monosodium salt, monohydrate bisodium salt, anhydrous monosodium salt and method for preparing compound 1
TWI794725B (en) 2015-04-01 2023-03-01 美商阿克比治療有限公司 Compositions and methods for treating anemia
US20180243271A1 (en) * 2015-05-28 2018-08-30 Japan Tobacco Inc. Method for Treating or Preventing Diabetic Nephropathy
KR102659552B1 (en) 2017-05-02 2024-04-23 코르테바 애그리사이언스 엘엘씨 Use of acyclic picolinamide compounds as fungicides against fungal diseases on turf grasses
TWI774761B (en) 2017-05-02 2022-08-21 美商科迪華農業科技有限責任公司 Synergistic mixtures for fungal control in cereals
TW201842851A (en) 2017-05-02 2018-12-16 美商陶氏農業科學公司 Synergistic mixture for fungal control in cereals
BR102019004480B1 (en) 2018-03-08 2023-03-28 Dow Agrosciences Llc PICOLINAMIDES AS FUNGICIDES
EP3790863A1 (en) 2018-05-09 2021-03-17 Akebia Therapeutics Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
EP3866597A4 (en) 2018-10-15 2022-06-29 Corteva Agriscience LLC Methods for sythesis of oxypicolinamides
BR112022007354A2 (en) 2019-10-18 2022-08-23 Corteva Agriscience Llc PROCESS FOR SYNTHESIS OF PICOLINAMIDES
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE149485T1 (en) * 1993-11-02 1997-03-15 Hoechst Ag SUBSTITUTED HETEROCYCLIC CARBOXYLIC AMIDE ESTERS, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
WO1997041103A1 (en) 1997-11-06
KR20000065090A (en) 2000-11-06
CA2253282A1 (en) 1997-11-06
EP0900202A1 (en) 1999-03-10
NO984878L (en) 1998-12-29
JP2000509047A (en) 2000-07-18
NO984878D0 (en) 1998-10-19

Similar Documents

Publication Publication Date Title
AU5762896A (en) 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and the ir use as drugs
AU2103097A (en) Cinnoline derivatives and use as medicine
AU4679297A (en) 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
AU3772797A (en) Polynucleotide vaccine formulation against pathologies of the horse
AU4172597A (en) Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
AU4777097A (en) Novel piperidineketocarboxylic acid derivatives, their preparation and use
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU2294097A (en) Novel carboxylic acid derivatives, their preparation and use
AU2636497A (en) Novel carboxylic acid derivatives, their preparation and use
AU3695297A (en) Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
AU5443499A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
HUP9802332A3 (en) Fungicidal carbamoyl carboxylic acid amide derivatives, preparation and use thereof
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU6929596A (en) Novel carboxylic acid derivatives, their preparation and use
AU3023497A (en) Phthalazine derivatives, their preparation and their use as drugs
AU695918B2 (en) Iminooxybenzylcrotonate esters, their preparation and their use
IL131370A0 (en) N'-substituted- n,n'-diacylhydrazines their preparation from benzodioxincarboxylic acids and esters and use thereof as insecticides
AU3551697A (en) Carboxylic acid esters, and compositions comprising them
AU3806495A (en) Dithiocarbazonic acid butenyl esters and their use as pesticides
AU4318397A (en) Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
AU5923994A (en) 4-alkyl-3-chlorobenzenesulfinic acids, 4-alkyl-3- chlorobenzenesulfonylcarboxylic acids, 4-alkyl-3- chloroalkylsulfonylbenzenes and preparation thereof
AU4314693A (en) Pyrimidinyl- and triazinyl- salicyl- and picolylamides and the use, as herbicides, and preparation thereof

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted